| 查看: 636 | 回复: 0 | |||
secwhite新虫 (初入文坛)
|
[交流]
招收 postdocs, PhD/MS graduate students（化学、材料、生物方向）
|
|
导师简介： Dr. Zhu is an NIH KL2 scholar (2019-2021) and Assistant Professor of Pharmaceutics at VCU. He received his BS (2008) in Biotechnology from Nankai University, China, and completed Ph.D. (2013) in Medical Sciences at the University of Florida College of Medicine. Dr. Zhu was a postdoc at NIBIB/NIH. His research interests lie at the interface of immune-oncology, nucleic acid therapeutics, nanomedicine, pharmacoengineering and pharmacoimaging. 研究方向： Our research interests lie at the interface of immune-oncology, nucleic acid theranostics, immunotherapy, and functional biomaterials. My current focus is to develop therapeutics and vaccines for combination cancer immunotherapy, infectious disease prevention, and drug abuse treatment. Current primary research directions are listed below. 1. mRNA vaccines for cancer immunotherapy and infectious disease prophylaxis. 2. Novel nucleic acid immunotherapeutics for cancer immunotherapy (immunomodulatory DNA/RNA, mRNA, gene-editing gRNA, siRNA, aptamer) 3. ADAR-targeted nucleic acid theranostics and immunomodulators 4. Drug and vaccine delivery 5. Biomaterials: Nanovaccine/Nanomedicine, polymer microneedle patches, hydrogel 联系方式： Email: gzhu2@vcu.edu or zhu.julian21@gmail.com Wechat: Guizhi_Zhu Website: https://guizhizhu.org 欢迎感兴趣的朋友咨询和投递简历至Dr. Zhu邮箱或微信联系，或站内联系我。谢谢大家！ |
回复此楼» 本帖附件资源列表
-
欢迎监督和反馈：小木虫仅提供交流平台，不对该内容负责。
本内容由用户自主发布，如果其内容涉及到知识产权问题，其责任在于用户本人，如对版权有异议，请联系邮箱：xiaomuchong@tal.com - 附件 1 : Postdoc_Grad_Ad_Zhu.pdf
2022-11-18 07:43:57, 117.98 K
» 猜你喜欢
烦躁
已经有4人回复
-
系统里面怎么还是等待基金委接收纸质
已经有3人回复
-
寻找合作团队
已经有4人回复
» 本主题相关商家推荐: (我也要在这里推广)
